Kinetic and pharmacological studies on estazolam in mice and man

A. Mancinelli, G. Guiso, S. Garattini, R. Urso, S. Caccia

Research output: Contribution to journalArticle

Abstract

1. After i.v. and oral doses of estazolam (5 mg/kg) to mice, the drug was rapidly cleared with a half-life (t1/2 of 0.7 h. 2. The active metabolite, 1-oxo-estazolam, was present in traces in mouse plasma and brain. Its elimination t1/2 ( determined after i.v. injection of 1-oxo-estazolam (5 mg/kg) to mice, was similar to that of the parent drug in both plasma and brain. 3. After a single oral dose of estazolam (4mg) to four human volunteers the drug was rapidly absorbed and reached maximum plasma concentrations in one to three hours. Elimination t1/2 of estazolam in humans was 19 h. 4. The metabolite was undetectable in human plasma after either single or multiple doses of estazolam. 5. These results, together with the finding that 1-oxo-estazolam was less effective than estazolam, in terms of ED50 and brain concentrations necessary to antagonize leptazol convulsions and disrupt rota-rod performance in mice, indicate that the metabolite does not contribute significantly to the pharmacological effects of its parent drug.

Original languageEnglish
Pages (from-to)257-265
Number of pages9
JournalXenobiotica
Volume15
Issue number3
DOIs
Publication statusPublished - 1985

Fingerprint

Estazolam
Pharmacology
Metabolites
Kinetics
Brain
Plasmas
Pharmaceutical Preparations
Parents
Plasma (human)
Half-Life
Volunteers
Seizures
Injections
1-oxoestazolam

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Biochemistry
  • Health, Toxicology and Mutagenesis
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kinetic and pharmacological studies on estazolam in mice and man. / Mancinelli, A.; Guiso, G.; Garattini, S.; Urso, R.; Caccia, S.

In: Xenobiotica, Vol. 15, No. 3, 1985, p. 257-265.

Research output: Contribution to journalArticle

Mancinelli, A. ; Guiso, G. ; Garattini, S. ; Urso, R. ; Caccia, S. / Kinetic and pharmacological studies on estazolam in mice and man. In: Xenobiotica. 1985 ; Vol. 15, No. 3. pp. 257-265.
@article{4b184a2098444307a15178eeb1de96fd,
title = "Kinetic and pharmacological studies on estazolam in mice and man",
abstract = "1. After i.v. and oral doses of estazolam (5 mg/kg) to mice, the drug was rapidly cleared with a half-life (t1/2 of 0.7 h. 2. The active metabolite, 1-oxo-estazolam, was present in traces in mouse plasma and brain. Its elimination t1/2 ( determined after i.v. injection of 1-oxo-estazolam (5 mg/kg) to mice, was similar to that of the parent drug in both plasma and brain. 3. After a single oral dose of estazolam (4mg) to four human volunteers the drug was rapidly absorbed and reached maximum plasma concentrations in one to three hours. Elimination t1/2 of estazolam in humans was 19 h. 4. The metabolite was undetectable in human plasma after either single or multiple doses of estazolam. 5. These results, together with the finding that 1-oxo-estazolam was less effective than estazolam, in terms of ED50 and brain concentrations necessary to antagonize leptazol convulsions and disrupt rota-rod performance in mice, indicate that the metabolite does not contribute significantly to the pharmacological effects of its parent drug.",
author = "A. Mancinelli and G. Guiso and S. Garattini and R. Urso and S. Caccia",
year = "1985",
doi = "10.3109/00498258509045357",
language = "English",
volume = "15",
pages = "257--265",
journal = "Xenobiotica",
issn = "0049-8254",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Kinetic and pharmacological studies on estazolam in mice and man

AU - Mancinelli, A.

AU - Guiso, G.

AU - Garattini, S.

AU - Urso, R.

AU - Caccia, S.

PY - 1985

Y1 - 1985

N2 - 1. After i.v. and oral doses of estazolam (5 mg/kg) to mice, the drug was rapidly cleared with a half-life (t1/2 of 0.7 h. 2. The active metabolite, 1-oxo-estazolam, was present in traces in mouse plasma and brain. Its elimination t1/2 ( determined after i.v. injection of 1-oxo-estazolam (5 mg/kg) to mice, was similar to that of the parent drug in both plasma and brain. 3. After a single oral dose of estazolam (4mg) to four human volunteers the drug was rapidly absorbed and reached maximum plasma concentrations in one to three hours. Elimination t1/2 of estazolam in humans was 19 h. 4. The metabolite was undetectable in human plasma after either single or multiple doses of estazolam. 5. These results, together with the finding that 1-oxo-estazolam was less effective than estazolam, in terms of ED50 and brain concentrations necessary to antagonize leptazol convulsions and disrupt rota-rod performance in mice, indicate that the metabolite does not contribute significantly to the pharmacological effects of its parent drug.

AB - 1. After i.v. and oral doses of estazolam (5 mg/kg) to mice, the drug was rapidly cleared with a half-life (t1/2 of 0.7 h. 2. The active metabolite, 1-oxo-estazolam, was present in traces in mouse plasma and brain. Its elimination t1/2 ( determined after i.v. injection of 1-oxo-estazolam (5 mg/kg) to mice, was similar to that of the parent drug in both plasma and brain. 3. After a single oral dose of estazolam (4mg) to four human volunteers the drug was rapidly absorbed and reached maximum plasma concentrations in one to three hours. Elimination t1/2 of estazolam in humans was 19 h. 4. The metabolite was undetectable in human plasma after either single or multiple doses of estazolam. 5. These results, together with the finding that 1-oxo-estazolam was less effective than estazolam, in terms of ED50 and brain concentrations necessary to antagonize leptazol convulsions and disrupt rota-rod performance in mice, indicate that the metabolite does not contribute significantly to the pharmacological effects of its parent drug.

UR - http://www.scopus.com/inward/record.url?scp=0021863799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021863799&partnerID=8YFLogxK

U2 - 10.3109/00498258509045357

DO - 10.3109/00498258509045357

M3 - Article

C2 - 2862746

AN - SCOPUS:0021863799

VL - 15

SP - 257

EP - 265

JO - Xenobiotica

JF - Xenobiotica

SN - 0049-8254

IS - 3

ER -